InflaRx (IFRX) Total Liabilities (2016 - 2026)

InflaRx has disclosed Total Liabilities across 11 years of filings, most recently posting $14.0 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $14.0 million, down 19.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.0 million (down 19.23% YoY), and the FY2025 annual result was $15.9 million, up 1.9% from the prior year.
• Total Liabilities came in at $14.0 million for Q1 2026 at InflaRx, down from $15.9 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $23.1 million in Q3 2025 to a low of $8.3 million in Q1 2023.
• The 5-year median for Total Liabilities is $14.3 million (2022), against an average of $15.1 million.
• Across the five-year window, Total Liabilities soared 121.11% in 2022 and sank 62.95% in 2023, its largest moves.
• InflaRx's Total Liabilities stood at $14.3 million in 2022, then soared by 32.3% to $19.0 million in 2023, then decreased by 17.72% to $15.6 million in 2024, then climbed by 1.9% to $15.9 million in 2025, then slipped by 11.65% to $14.0 million in 2026.
• The last three Total Liabilities figures came in at $14.0 million (Q1 2026), $15.9 million (Q4 2025), and $23.1 million (Q3 2025), per Business Quant data.